1. Home
  2. BTU vs SUPN Comparison

BTU vs SUPN Comparison

Compare BTU & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Peabody Energy Corporation

BTU

Peabody Energy Corporation

HOLD

Current Price

$23.20

Market Cap

3.2B

Sector

Energy

ML Signal

HOLD

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

HOLD

Current Price

$45.25

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BTU
SUPN
Founded
2016
2005
Country
United States
United States
Employees
6600
N/A
Industry
Coal Mining
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
3.0B
IPO Year
2001
2010

Fundamental Metrics

Financial Performance
Metric
BTU
SUPN
Price
$23.20
$45.25
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
5
Target Price
$32.83
$61.60
AVG Volume (30 Days)
3.7M
571.0K
Earning Date
05-05-2026
05-05-2026
Dividend Yield
1.09%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$3,861,500,000.00
$392,755,000.00
Revenue This Year
$17.96
$22.70
Revenue Next Year
$5.47
$19.14
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.67
$31.16
52 Week High
$41.14
$59.68

Technical Indicators

Market Signals
Indicator
BTU
SUPN
Relative Strength Index (RSI) 36.16 47.46
Support Level N/A $43.43
Resistance Level $31.39 $46.79
Average True Range (ATR) 1.31 1.34
MACD -0.45 0.20
Stochastic Oscillator 1.79 71.19

Price Performance

Historical Comparison
BTU
SUPN

About BTU Peabody Energy Corporation

Peabody Energy Corp is a producer of metallurgical and thermal coal. It also markets and brokers coal, both as principal and agent, and trades coal and freight-related contracts. The company operates in the following segment: Seaborne Thermal, Seaborne Metallurgical, Powder River Basin, Other U.S. Thermal and Corporate and Other. The Seaborne Thermal segment generates the majority of the revenue for the company. A substantial part of its overall revenue is generated from its customers in the United States, and rest from Japan, China, Australia, Taiwan, and other regions.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.

Share on Social Networks: